- Home
- IPSC vs IPWR Comparison
IPSC vs IPWR Comparison
Compare IPSC & IPWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPSC
- IPWR
- Stock Information
- Founded
- IPSC 2019
- IPWR 2007
- Country
- IPSC United States
- IPWR United States
- Employees
- IPSC N/A
- IPWR N/A
- Industry
- IPSC Medicinal Chemicals and Botanical Products
- IPWR Industrial Machinery/Components
- Sector
- IPSC Health Care
- IPWR Industrials
- Exchange
- IPSC Nasdaq
- IPWR Nasdaq
- Market Cap
- IPSC 49.6M
- IPWR 42.1M
- IPO Year
- IPSC 2021
- IPWR 2013
- Fundamental
- Price
- IPSC $0.60
- IPWR $6.15
- Analyst Decision
- IPSC Strong Buy
- IPWR Hold
- Analyst Count
- IPSC 5
- IPWR 1
- Target Price
- IPSC $3.33
- IPWR N/A
- AVG Volume (30 Days)
- IPSC 1.0M
- IPWR 69.1K
- Earning Date
- IPSC 08-07-2025
- IPWR 08-13-2025
- Dividend Yield
- IPSC N/A
- IPWR N/A
- EPS Growth
- IPSC N/A
- IPWR N/A
- EPS
- IPSC N/A
- IPWR N/A
- Revenue
- IPSC $114,898,000.00
- IPWR $19,296.00
- Revenue This Year
- IPSC $1,064.82
- IPWR N/A
- Revenue Next Year
- IPSC N/A
- IPWR $5,900.00
- P/E Ratio
- IPSC N/A
- IPWR N/A
- Revenue Growth
- IPSC 8286.72
- IPWR N/A
- 52 Week Low
- IPSC $0.34
- IPWR $3.77
- 52 Week High
- IPSC $3.29
- IPWR $9.69
- Technical
- Relative Strength Index (RSI)
- IPSC 55.47
- IPWR 76.18
- Support Level
- IPSC $0.52
- IPWR $4.56
- Resistance Level
- IPSC $0.57
- IPWR $4.83
- Average True Range (ATR)
- IPSC 0.04
- IPWR 0.45
- MACD
- IPSC 0.00
- IPWR 0.22
- Stochastic Oscillator
- IPSC 66.10
- IPWR 89.44
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.
About IPWR Ideal Power Inc.
Ideal Power Inc is pioneering the development of its broadly patented bidirectional power switches, creating efficient and ecofriendly energy control solutions for electric vehicles, electric vehicle charging, renewable energy, energy storage, UPS / data center, solid-state circuit breaker and other industrial and military applications. The company is focused on its patented Bidirectional, Bipolar Junction Transistor (B-TRAN) semiconductor technology. B-TRAN is a double-sided bidirectional AC switchable to deliver substantial performance improvements over conventional power semiconductors. The primary raw material used in the fabrication of B-TRAN devices is silicon wafers.